The association of single nucleotide polymorphisms in the oxytocin receptor and G protein-coupled receptor kinase 6 (GRK6) genes with oxytocin dosing requirements and labor outcomes

Abstract Background Oxytocin is a potent uterotonic agent that is widely used for induction and augmentation of labor. Oxytocin has a narrow therapeutic index and the optimal dosing for any individual woman varies widely. Objective The objective of this study was to determine if genetic variation in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of obstetrics and gynecology 2017-09, Vol.217 (3), p.367.e1-367.e9
Hauptverfasser: Grotegut, Chad A., MD MHS, Ngan, Emily, Ms, Garrett, Melanie E., Ms, Miranda, Marie Lynn, PhD, Ashley-Koch, Allison E., PhD, Swamy, Geeta K., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 367.e9
container_issue 3
container_start_page 367.e1
container_title American journal of obstetrics and gynecology
container_volume 217
creator Grotegut, Chad A., MD MHS
Ngan, Emily, Ms
Garrett, Melanie E., Ms
Miranda, Marie Lynn, PhD
Ashley-Koch, Allison E., PhD
Swamy, Geeta K., MD
description Abstract Background Oxytocin is a potent uterotonic agent that is widely used for induction and augmentation of labor. Oxytocin has a narrow therapeutic index and the optimal dosing for any individual woman varies widely. Objective The objective of this study was to determine if genetic variation in the oxytocin receptor (OXTR) or in the gene encoding G protein-coupled receptor kinase 6 (GRK6), which regulates desensitization of the OXTR, could explain variation in oxytocin dosing and labor outcomes among women being induced near term. Study Design Pregnant women with a singleton gestation residing in Durham County, NC were prospectively enrolled as part of the Healthy Pregnancy, Healthy Baby cohort study. Those women undergoing an induction of labor at 36 weeks or greater were genotyped for 18 haplotype tagging (ht) single nucleotide polymorphisms (SNPs) in OXTR and 7 htSNPs in GRK6 using TaqMan assays. Linear regression was used to examine the relationship between maternal genotype and maximal oxytocin infusion rate, total oxytocin dose received, and duration of labor. Logistic regression was used to test for association of maternal genotype with mode of delivery. For each outcome, backward selection techniques were utilized to control for important confounding variables and additive genetic models were employed. Race/ethnicity was included in all models due to differences in allele frequencies across populations and Bonferroni correction for multiple testing was used. Results DNA was available from 482 women undergoing induction of labor at 36 weeks or greater. 18 SNPs within OXTR and 7 SNPs within GRK6 were examined. Five SNPs in OXTR showed nominal significance with maximal infusion rate of oxytocin and two SNPs in OXTR were associated with total oxytocin dose received. One SNP in OXTR and two SNPs in GRK6 were associated with duration of labor, one of which met the multiple testing threshold (p=0.0014, rs2731664 [ GRK6 ], mean duration of labor 17.7 hours vs. 20.2 hours vs. 23.5 hours for AA, AC and CC genotypes, respectively). Three SNPs, two in OXTR and one in GRK6 , showed nominal significance with mode of delivery. Conclusions Genetic variation in OXTR and GRK6 is associated with the amount of oxytocin required, as well as the duration of labor and risk for cesarean delivery among women undergoing induction of labor near term. With further research, pharmacogenomic approaches may potentially be utilized to develop personalized treatment to improv
doi_str_mv 10.1016/j.ajog.2017.05.023
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5581254</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002937817306324</els_id><sourcerecordid>1900832736</sourcerecordid><originalsourceid>FETCH-LOGICAL-c510t-7624ef58ffe2965f2b1d0922bbb777f43146b5e6da0b05ccd56c96b2b0ab9da3</originalsourceid><addsrcrecordid>eNp9ksFu1DAQhiMEokvhBTggH8shi-3ETiKhSlUFC6ISEuzdsp3JrtPETm2nsA_G--GwpQUOnCxr_v-b0fyTZS8JXhNM-Jt-LXu3W1NMqjVma0yLR9mK4KbKec3rx9kKY0zzpqjqk-xZCP3ypQ19mp3QmlFeMrzKfmz3gGQIThsZjbPIdSgYuxsA2VkP4KJpAU1uOIzOT3sTxoCMRTG53PdDTDaLPGiYovNI2hZt0ORdBGNz7eZpgPahfG2sDIA4Ott8-cRfox1YCOibifsHVuuW7slzMxsPI9gYfmEHqRLBzVG7EcLz7EknhwAv7t7TbPv-3fbyQ371efPx8uIq14zgmFecltCxuuuANpx1VJEWN5Qqpaqq6sqClFwx4K3ECjOtW8Z1wxVVWKqmlcVpdn7ETrMaodVpGi8HMXkzSn8QThrxd8Wavdi5W8FYTSgrE-DsDuDdzQwhitEEDcMgLbg5CNJgXBe0KniS0qNUexeCh-6-DcFiiVv0YolbLHELzESKO5le_TngveV3vknw9iiAtKVbA14EbcBqaNN2dRStM__nn_9j14OxRsvhGg4Qejd7m_YviAhUYPF1ubDl3khVYF7QsvgJdQbW4w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1900832736</pqid></control><display><type>article</type><title>The association of single nucleotide polymorphisms in the oxytocin receptor and G protein-coupled receptor kinase 6 (GRK6) genes with oxytocin dosing requirements and labor outcomes</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Grotegut, Chad A., MD MHS ; Ngan, Emily, Ms ; Garrett, Melanie E., Ms ; Miranda, Marie Lynn, PhD ; Ashley-Koch, Allison E., PhD ; Swamy, Geeta K., MD</creator><creatorcontrib>Grotegut, Chad A., MD MHS ; Ngan, Emily, Ms ; Garrett, Melanie E., Ms ; Miranda, Marie Lynn, PhD ; Ashley-Koch, Allison E., PhD ; Swamy, Geeta K., MD</creatorcontrib><description>Abstract Background Oxytocin is a potent uterotonic agent that is widely used for induction and augmentation of labor. Oxytocin has a narrow therapeutic index and the optimal dosing for any individual woman varies widely. Objective The objective of this study was to determine if genetic variation in the oxytocin receptor (OXTR) or in the gene encoding G protein-coupled receptor kinase 6 (GRK6), which regulates desensitization of the OXTR, could explain variation in oxytocin dosing and labor outcomes among women being induced near term. Study Design Pregnant women with a singleton gestation residing in Durham County, NC were prospectively enrolled as part of the Healthy Pregnancy, Healthy Baby cohort study. Those women undergoing an induction of labor at 36 weeks or greater were genotyped for 18 haplotype tagging (ht) single nucleotide polymorphisms (SNPs) in OXTR and 7 htSNPs in GRK6 using TaqMan assays. Linear regression was used to examine the relationship between maternal genotype and maximal oxytocin infusion rate, total oxytocin dose received, and duration of labor. Logistic regression was used to test for association of maternal genotype with mode of delivery. For each outcome, backward selection techniques were utilized to control for important confounding variables and additive genetic models were employed. Race/ethnicity was included in all models due to differences in allele frequencies across populations and Bonferroni correction for multiple testing was used. Results DNA was available from 482 women undergoing induction of labor at 36 weeks or greater. 18 SNPs within OXTR and 7 SNPs within GRK6 were examined. Five SNPs in OXTR showed nominal significance with maximal infusion rate of oxytocin and two SNPs in OXTR were associated with total oxytocin dose received. One SNP in OXTR and two SNPs in GRK6 were associated with duration of labor, one of which met the multiple testing threshold (p=0.0014, rs2731664 [ GRK6 ], mean duration of labor 17.7 hours vs. 20.2 hours vs. 23.5 hours for AA, AC and CC genotypes, respectively). Three SNPs, two in OXTR and one in GRK6 , showed nominal significance with mode of delivery. Conclusions Genetic variation in OXTR and GRK6 is associated with the amount of oxytocin required, as well as the duration of labor and risk for cesarean delivery among women undergoing induction of labor near term. With further research, pharmacogenomic approaches may potentially be utilized to develop personalized treatment to improve safety and efficacy outcomes among women undergoing induction of labor.</description><identifier>ISSN: 0002-9378</identifier><identifier>EISSN: 1097-6868</identifier><identifier>DOI: 10.1016/j.ajog.2017.05.023</identifier><identifier>PMID: 28526450</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; desensitization ; Dose-Response Relationship, Drug ; Female ; G protein–coupled receptor ; G protein–coupled receptor kinase 6 ; G-Protein-Coupled Receptor Kinases - genetics ; Genotype ; GRK6 ; Humans ; induction of labor ; labor ; Labor, Induced ; Obstetrics and Gynecology ; Oxytocics - administration &amp; dosage ; oxytocin ; Oxytocin - administration &amp; dosage ; oxytocin receptor ; Pharmacogenomic Testing ; Polymorphism, Single Nucleotide ; Pregnancy ; Prospective Studies ; Receptors, Oxytocin - genetics ; single-nucleotide polymorphism ; Time Factors ; β-arrestin</subject><ispartof>American journal of obstetrics and gynecology, 2017-09, Vol.217 (3), p.367.e1-367.e9</ispartof><rights>Elsevier Inc.</rights><rights>2017 Elsevier Inc.</rights><rights>Copyright © 2017 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c510t-7624ef58ffe2965f2b1d0922bbb777f43146b5e6da0b05ccd56c96b2b0ab9da3</citedby><cites>FETCH-LOGICAL-c510t-7624ef58ffe2965f2b1d0922bbb777f43146b5e6da0b05ccd56c96b2b0ab9da3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ajog.2017.05.023$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28526450$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Grotegut, Chad A., MD MHS</creatorcontrib><creatorcontrib>Ngan, Emily, Ms</creatorcontrib><creatorcontrib>Garrett, Melanie E., Ms</creatorcontrib><creatorcontrib>Miranda, Marie Lynn, PhD</creatorcontrib><creatorcontrib>Ashley-Koch, Allison E., PhD</creatorcontrib><creatorcontrib>Swamy, Geeta K., MD</creatorcontrib><title>The association of single nucleotide polymorphisms in the oxytocin receptor and G protein-coupled receptor kinase 6 (GRK6) genes with oxytocin dosing requirements and labor outcomes</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><description>Abstract Background Oxytocin is a potent uterotonic agent that is widely used for induction and augmentation of labor. Oxytocin has a narrow therapeutic index and the optimal dosing for any individual woman varies widely. Objective The objective of this study was to determine if genetic variation in the oxytocin receptor (OXTR) or in the gene encoding G protein-coupled receptor kinase 6 (GRK6), which regulates desensitization of the OXTR, could explain variation in oxytocin dosing and labor outcomes among women being induced near term. Study Design Pregnant women with a singleton gestation residing in Durham County, NC were prospectively enrolled as part of the Healthy Pregnancy, Healthy Baby cohort study. Those women undergoing an induction of labor at 36 weeks or greater were genotyped for 18 haplotype tagging (ht) single nucleotide polymorphisms (SNPs) in OXTR and 7 htSNPs in GRK6 using TaqMan assays. Linear regression was used to examine the relationship between maternal genotype and maximal oxytocin infusion rate, total oxytocin dose received, and duration of labor. Logistic regression was used to test for association of maternal genotype with mode of delivery. For each outcome, backward selection techniques were utilized to control for important confounding variables and additive genetic models were employed. Race/ethnicity was included in all models due to differences in allele frequencies across populations and Bonferroni correction for multiple testing was used. Results DNA was available from 482 women undergoing induction of labor at 36 weeks or greater. 18 SNPs within OXTR and 7 SNPs within GRK6 were examined. Five SNPs in OXTR showed nominal significance with maximal infusion rate of oxytocin and two SNPs in OXTR were associated with total oxytocin dose received. One SNP in OXTR and two SNPs in GRK6 were associated with duration of labor, one of which met the multiple testing threshold (p=0.0014, rs2731664 [ GRK6 ], mean duration of labor 17.7 hours vs. 20.2 hours vs. 23.5 hours for AA, AC and CC genotypes, respectively). Three SNPs, two in OXTR and one in GRK6 , showed nominal significance with mode of delivery. Conclusions Genetic variation in OXTR and GRK6 is associated with the amount of oxytocin required, as well as the duration of labor and risk for cesarean delivery among women undergoing induction of labor near term. With further research, pharmacogenomic approaches may potentially be utilized to develop personalized treatment to improve safety and efficacy outcomes among women undergoing induction of labor.</description><subject>Adult</subject><subject>desensitization</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>G protein–coupled receptor</subject><subject>G protein–coupled receptor kinase 6</subject><subject>G-Protein-Coupled Receptor Kinases - genetics</subject><subject>Genotype</subject><subject>GRK6</subject><subject>Humans</subject><subject>induction of labor</subject><subject>labor</subject><subject>Labor, Induced</subject><subject>Obstetrics and Gynecology</subject><subject>Oxytocics - administration &amp; dosage</subject><subject>oxytocin</subject><subject>Oxytocin - administration &amp; dosage</subject><subject>oxytocin receptor</subject><subject>Pharmacogenomic Testing</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Pregnancy</subject><subject>Prospective Studies</subject><subject>Receptors, Oxytocin - genetics</subject><subject>single-nucleotide polymorphism</subject><subject>Time Factors</subject><subject>β-arrestin</subject><issn>0002-9378</issn><issn>1097-6868</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9ksFu1DAQhiMEokvhBTggH8shi-3ETiKhSlUFC6ISEuzdsp3JrtPETm2nsA_G--GwpQUOnCxr_v-b0fyTZS8JXhNM-Jt-LXu3W1NMqjVma0yLR9mK4KbKec3rx9kKY0zzpqjqk-xZCP3ypQ19mp3QmlFeMrzKfmz3gGQIThsZjbPIdSgYuxsA2VkP4KJpAU1uOIzOT3sTxoCMRTG53PdDTDaLPGiYovNI2hZt0ORdBGNz7eZpgPahfG2sDIA4Ott8-cRfox1YCOibifsHVuuW7slzMxsPI9gYfmEHqRLBzVG7EcLz7EknhwAv7t7TbPv-3fbyQ371efPx8uIq14zgmFecltCxuuuANpx1VJEWN5Qqpaqq6sqClFwx4K3ECjOtW8Z1wxVVWKqmlcVpdn7ETrMaodVpGi8HMXkzSn8QThrxd8Wavdi5W8FYTSgrE-DsDuDdzQwhitEEDcMgLbg5CNJgXBe0KniS0qNUexeCh-6-DcFiiVv0YolbLHELzESKO5le_TngveV3vknw9iiAtKVbA14EbcBqaNN2dRStM__nn_9j14OxRsvhGg4Qejd7m_YviAhUYPF1ubDl3khVYF7QsvgJdQbW4w</recordid><startdate>20170901</startdate><enddate>20170901</enddate><creator>Grotegut, Chad A., MD MHS</creator><creator>Ngan, Emily, Ms</creator><creator>Garrett, Melanie E., Ms</creator><creator>Miranda, Marie Lynn, PhD</creator><creator>Ashley-Koch, Allison E., PhD</creator><creator>Swamy, Geeta K., MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170901</creationdate><title>The association of single nucleotide polymorphisms in the oxytocin receptor and G protein-coupled receptor kinase 6 (GRK6) genes with oxytocin dosing requirements and labor outcomes</title><author>Grotegut, Chad A., MD MHS ; Ngan, Emily, Ms ; Garrett, Melanie E., Ms ; Miranda, Marie Lynn, PhD ; Ashley-Koch, Allison E., PhD ; Swamy, Geeta K., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c510t-7624ef58ffe2965f2b1d0922bbb777f43146b5e6da0b05ccd56c96b2b0ab9da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>desensitization</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>G protein–coupled receptor</topic><topic>G protein–coupled receptor kinase 6</topic><topic>G-Protein-Coupled Receptor Kinases - genetics</topic><topic>Genotype</topic><topic>GRK6</topic><topic>Humans</topic><topic>induction of labor</topic><topic>labor</topic><topic>Labor, Induced</topic><topic>Obstetrics and Gynecology</topic><topic>Oxytocics - administration &amp; dosage</topic><topic>oxytocin</topic><topic>Oxytocin - administration &amp; dosage</topic><topic>oxytocin receptor</topic><topic>Pharmacogenomic Testing</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Pregnancy</topic><topic>Prospective Studies</topic><topic>Receptors, Oxytocin - genetics</topic><topic>single-nucleotide polymorphism</topic><topic>Time Factors</topic><topic>β-arrestin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grotegut, Chad A., MD MHS</creatorcontrib><creatorcontrib>Ngan, Emily, Ms</creatorcontrib><creatorcontrib>Garrett, Melanie E., Ms</creatorcontrib><creatorcontrib>Miranda, Marie Lynn, PhD</creatorcontrib><creatorcontrib>Ashley-Koch, Allison E., PhD</creatorcontrib><creatorcontrib>Swamy, Geeta K., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grotegut, Chad A., MD MHS</au><au>Ngan, Emily, Ms</au><au>Garrett, Melanie E., Ms</au><au>Miranda, Marie Lynn, PhD</au><au>Ashley-Koch, Allison E., PhD</au><au>Swamy, Geeta K., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The association of single nucleotide polymorphisms in the oxytocin receptor and G protein-coupled receptor kinase 6 (GRK6) genes with oxytocin dosing requirements and labor outcomes</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>2017-09-01</date><risdate>2017</risdate><volume>217</volume><issue>3</issue><spage>367.e1</spage><epage>367.e9</epage><pages>367.e1-367.e9</pages><issn>0002-9378</issn><eissn>1097-6868</eissn><abstract>Abstract Background Oxytocin is a potent uterotonic agent that is widely used for induction and augmentation of labor. Oxytocin has a narrow therapeutic index and the optimal dosing for any individual woman varies widely. Objective The objective of this study was to determine if genetic variation in the oxytocin receptor (OXTR) or in the gene encoding G protein-coupled receptor kinase 6 (GRK6), which regulates desensitization of the OXTR, could explain variation in oxytocin dosing and labor outcomes among women being induced near term. Study Design Pregnant women with a singleton gestation residing in Durham County, NC were prospectively enrolled as part of the Healthy Pregnancy, Healthy Baby cohort study. Those women undergoing an induction of labor at 36 weeks or greater were genotyped for 18 haplotype tagging (ht) single nucleotide polymorphisms (SNPs) in OXTR and 7 htSNPs in GRK6 using TaqMan assays. Linear regression was used to examine the relationship between maternal genotype and maximal oxytocin infusion rate, total oxytocin dose received, and duration of labor. Logistic regression was used to test for association of maternal genotype with mode of delivery. For each outcome, backward selection techniques were utilized to control for important confounding variables and additive genetic models were employed. Race/ethnicity was included in all models due to differences in allele frequencies across populations and Bonferroni correction for multiple testing was used. Results DNA was available from 482 women undergoing induction of labor at 36 weeks or greater. 18 SNPs within OXTR and 7 SNPs within GRK6 were examined. Five SNPs in OXTR showed nominal significance with maximal infusion rate of oxytocin and two SNPs in OXTR were associated with total oxytocin dose received. One SNP in OXTR and two SNPs in GRK6 were associated with duration of labor, one of which met the multiple testing threshold (p=0.0014, rs2731664 [ GRK6 ], mean duration of labor 17.7 hours vs. 20.2 hours vs. 23.5 hours for AA, AC and CC genotypes, respectively). Three SNPs, two in OXTR and one in GRK6 , showed nominal significance with mode of delivery. Conclusions Genetic variation in OXTR and GRK6 is associated with the amount of oxytocin required, as well as the duration of labor and risk for cesarean delivery among women undergoing induction of labor near term. With further research, pharmacogenomic approaches may potentially be utilized to develop personalized treatment to improve safety and efficacy outcomes among women undergoing induction of labor.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28526450</pmid><doi>10.1016/j.ajog.2017.05.023</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9378
ispartof American journal of obstetrics and gynecology, 2017-09, Vol.217 (3), p.367.e1-367.e9
issn 0002-9378
1097-6868
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5581254
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adult
desensitization
Dose-Response Relationship, Drug
Female
G protein–coupled receptor
G protein–coupled receptor kinase 6
G-Protein-Coupled Receptor Kinases - genetics
Genotype
GRK6
Humans
induction of labor
labor
Labor, Induced
Obstetrics and Gynecology
Oxytocics - administration & dosage
oxytocin
Oxytocin - administration & dosage
oxytocin receptor
Pharmacogenomic Testing
Polymorphism, Single Nucleotide
Pregnancy
Prospective Studies
Receptors, Oxytocin - genetics
single-nucleotide polymorphism
Time Factors
β-arrestin
title The association of single nucleotide polymorphisms in the oxytocin receptor and G protein-coupled receptor kinase 6 (GRK6) genes with oxytocin dosing requirements and labor outcomes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T07%3A21%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20association%20of%20single%20nucleotide%20polymorphisms%20in%20the%20oxytocin%20receptor%20and%20G%20protein-coupled%20receptor%20kinase%206%20(GRK6)%20genes%20with%20oxytocin%20dosing%20requirements%20and%20labor%20outcomes&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=Grotegut,%20Chad%20A.,%20MD%20MHS&rft.date=2017-09-01&rft.volume=217&rft.issue=3&rft.spage=367.e1&rft.epage=367.e9&rft.pages=367.e1-367.e9&rft.issn=0002-9378&rft.eissn=1097-6868&rft_id=info:doi/10.1016/j.ajog.2017.05.023&rft_dat=%3Cproquest_pubme%3E1900832736%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1900832736&rft_id=info:pmid/28526450&rft_els_id=1_s2_0_S0002937817306324&rfr_iscdi=true